How did IRMD's Q1 2025 EPS forecast compare to past trends?

Iradimed Corp's (IRMD) Q1 2025 EPS forecast is not currently available. However, based on available data, the company's EPS has shown a general upward trend over the past few years.

1. **Comparison to Recent Past Trends**: IRMD's EPS for Q4 2024 was $0.40, which was slightly below the estimated $0.41 but still represented a robust EPS. The annual EPS for 2024 was $1.50, again slightly below the estimated $1.51 but indicative of strong earnings.
2. **Trend Analysis**: IRMD's EPS has exhibited significant growth, with an increase from $0.75 in 2021 to $1.16 in 2023, reflecting a 36% and 13.73% improvement respectively. This trend suggests a strong financial performance and the company's ability to increase earnings over time.
3. **Forecast Considerations**: While there is no specific data on Q1 2025 EPS, the company's historical performance and recent trends suggest that IRMD is likely to maintain a strong EPS in the upcoming quarter. The company's record revenues and positive outlook support this expectation.

In conclusion, while the exact EPS for Q1 2025 is unknown, the company's consistent growth in EPS and the positive financial indicators suggest that IRMD is poised for a strong performance in the upcoming quarter.